The total number of scientific publications in Immunology and Microbiology in Canada has demonstrated fluctuating growth trends over the past decade. From 2013 to 2023, the sector has seen periods of both decline and growth, culminating in 992.53 publications in 2023. Key performance variations include significant increases in 2014 (8.42%) and 2021 (11.9%), as well as notable drops in 2016 (-9.94%). The most recent five-year compound annual growth rate (CAGR) stands at 4.63%, showcasing robust overall growth.
Looking forward, forecasted data from 2024 to 2028 suggest continued, albeit slightly slower, growth with a five-year CAGR at 1.3%. The projected total for 2028 is 1080 publications, reflecting a cumulative growth rate of 6.65% for the forecast period.
Future trends to watch for include increased publication rates driven by advancements in genomic technologies, biopharmaceuticals, and personalized medicine. Additionally, policy changes, funding allocation, and international collaborations could further influence the trajectory of scientific outputs in this field. Monitoring these trends will provide insights into the sustainability and innovation outcomes within Canada's Immunology and Microbiology research landscape.
